A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance
Clinical trial NCT07622550 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07622550
- Sponsor
- Jiangsu Cancer Institute & Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-15
- Primary completion
- 2027-12-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.